State “Essential Health Benefit” Benchmark Plans Include “Fairly Robust” Formularies So Far
This article was originally published in The Pink Sheet Daily
Executive Summary
According to a recent tally by Avalere, more than 30 states have either selected a benchmark plan or are progressing in that direction.
You may also be interested in...
HHS Essential Health Benefits Standard Would Allow Plans To Cover One Drug Per Category
Released Dec. 16, the HHS bulletin previews the regulatory approach the department plans to propose to define covered services under the EHB standard, which must be followed by plans participating in state-based insurance exchanges that will start operating in 2014 under the Affordable Care Act.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.